S 
Shanghai Rongtai Health Technology Corp 603579.SS · CNY
Consumer Discretionary · Shanghai · 🇨🇳 China
14.04
-0.07%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.57bn
FY2016FY2025
Net income
CN¥150.7m
FY2016FY2025
Free cash flow
CN¥62.9m
FY2016FY2025
Shareholders' equity
CN¥2.79bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.57bn | CN¥1.60bn | CN¥1.86bn | CN¥2.00bn | CN¥2.61bn | CN¥2.02bn | CN¥2.31bn | CN¥2.30bn | CN¥1.92bn | CN¥1.29bn |
| Gross profit | CN¥483.3m | CN¥502.0m | CN¥561.3m | CN¥528.5m | CN¥699.9m | CN¥577.2m | CN¥717.5m | CN¥779.5m | CN¥730.1m | CN¥487.9m |
| Research and development | CN¥93.3m | CN¥80.1m | CN¥80.2m | CN¥88.7m | CN¥119.2m | CN¥100.1m | CN¥122.6m | CN¥108.8m | CN¥101.1m | CN¥60.5m |
| Operating income | CN¥99.2m | CN¥210.4m | CN¥236.0m | CN¥186.5m | CN¥265.2m | CN¥200.4m | CN¥327.3m | CN¥293.2m | CN¥257.5m | CN¥236.6m |
| Net income | CN¥150.7m | CN¥191.9m | CN¥202.7m | CN¥164.2m | CN¥236.3m | CN¥193.0m | CN¥295.6m | CN¥249.2m | CN¥216.2m | CN¥206.6m |
| Diluted earnings per share | 0.84 | 0.97 | 1.19 | 0.95 | 1.36 | 1.07 | 1.66 | 1.38 | 1.26 | 1.53 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥3.57bn | CN¥3.74bn | CN¥3.38bn | CN¥3.42bn | CN¥3.28bn | CN¥2.95bn | CN¥2.46bn | CN¥2.17bn | CN¥2.19bn | CN¥1.08bn |
| Cash and short-term investments | — | CN¥1.07bn | CN¥1.40bn | CN¥1.38bn | CN¥1.32bn | CN¥993.1m | CN¥1.02bn | CN¥1.09bn | CN¥987.4m | CN¥551.5m |
| Total liabilities | CN¥785.8m | CN¥1.73bn | CN¥1.41bn | CN¥1.55bn | CN¥1.50bn | CN¥1.30bn | CN¥829.9m | CN¥668.7m | CN¥803.9m | CN¥623.0m |
| Debt | — | CN¥1.07bn | CN¥755.2m | CN¥1.01bn | CN¥697.4m | CN¥556.0m | CN¥30.1m | CN¥152.0m | CN¥150.0m | CN¥235.2m |
| Shareholders' equity | CN¥2.79bn | CN¥2.01bn | CN¥1.97bn | CN¥1.87bn | CN¥1.78bn | CN¥1.66bn | CN¥1.63bn | CN¥1.49bn | CN¥1.37bn | CN¥451.2m |
| Shares outstanding | 179m | 198m | 170m | 173m | 174m | 180m | 178m | 181m | 172m | 135m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥174.8m | CN¥168.1m | CN¥344.3m | CN¥236.8m | CN¥337.9m | CN¥275.6m | CN¥446.5m | CN¥261.4m | CN¥281.2m | CN¥175.7m |
| Capital spending | −CN¥111.9m | −CN¥151.1m | −CN¥89.6m | −CN¥100.7m | −CN¥141.5m | −CN¥190.1m | −CN¥161.4m | −CN¥130.6m | −CN¥158.6m | −CN¥84.0m |
| Free cash flow | CN¥62.9m | CN¥17.1m | CN¥254.7m | CN¥136.1m | CN¥196.5m | CN¥85.5m | CN¥285.1m | CN¥130.8m | CN¥122.6m | CN¥91.6m |
| Dividends paid | −CN¥61.9m | −CN¥199.8m | −CN¥78.1m | −CN¥94.6m | −CN¥68.0m | −CN¥204.6m | −CN¥41.9m | −CN¥137.3m | −CN¥49.6m | −CN¥69.5m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥548.6m | CN¥442.2m | CN¥424.7m | CN¥337.9m | CN¥415.2m | CN¥395.0m | CN¥432.6m | CN¥339.4m |
| Gross profit | CN¥153.6m | CN¥136.8m | CN¥114.8m | CN¥106.8m | CN¥133.1m | CN¥128.5m | CN¥124.4m | CN¥103.7m |
| Operating income | CN¥22.4m | CN¥33.8m | CN¥1.3m | CN¥20.8m | CN¥62.1m | CN¥53.2m | CN¥52.6m | CN¥35.8m |
| Net income | CN¥42.5m | CN¥69.7m | CN¥39.9m | CN¥25.5m | CN¥41.4m | CN¥43.9m | CN¥49.4m | CN¥31.2m |
| Diluted earnings per share | 0.24 | 0.39 | 0.22 | 0.14 | 0.23 | 0.24 | 0.25 | 0.16 |
| Cash from operations | — | — | — | −CN¥18.0m | CN¥124.0m | −CN¥34.0m | — | CN¥26.0m |
| Capital spending | −CN¥25.0m | −CN¥5.0m | −CN¥9.0m | −CN¥48.0m | −CN¥12.0m | −CN¥41.0m | −CN¥49.0m | −CN¥45.0m |
| Free cash flow | — | — | — | −CN¥66.0m | CN¥112.0m | −CN¥75.0m | — | −CN¥19.0m |
| Total assets | CN¥3.90bn | CN¥3.79bn | CN¥3.57bn | CN¥3.35bn | CN¥3.46bn | CN¥3.35bn | CN¥3.74bn | CN¥3.41bn |
| Cash and short-term investments | — | — | — | CN¥722.9m | CN¥749.5m | CN¥770.5m | CN¥1.07bn | CN¥1.01bn |
| Debt | — | — | — | CN¥160.5m | CN¥876.1m | CN¥773.5m | CN¥1.07bn | CN¥1.01bn |
| Shareholders' equity | CN¥2.76bn | CN¥2.86bn | CN¥2.79bn | CN¥2.75bn | CN¥2.05bn | CN¥2.07bn | CN¥2.01bn | CN¥1.94bn |
Financial ratios
Data as of 17 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 34.2% | 31.4% | 30.3% | 26.4% | 26.8% | 28.6% | — |
| Operating margin | 13.0% | 13.6% | 13.9% | 10.4% | 11.2% | 10.2% | — |
| Net margin | 9.6% | 12.0% | 10.9% | 8.2% | 9.0% | 9.6% | — |
| Return on equity | 5.4% | 9.5% | 10.3% | 8.8% | 13.3% | 11.6% | — |
| Return on assets | 4.2% | 5.1% | 6.0% | 4.8% | 7.2% | 6.5% | — |
| Free cash flow yield | 9.6% | 9.7% | 15.4% | 11.8% | 16.6% | 15.7% | — |
| Revenue growth | -1.5% | -13.9% | -7.5% | -23.3% | 29.3% | -12.7% | — |
| Earnings growth | -21.5% | -5.3% | 23.4% | -30.5% | 22.5% | -34.7% | — |
| Current ratio | 3.09x | 2.21x | 3.34x | 2.55x | 2.34x | 2.58x | — |
| Debt to equity | — | 0.53x | 0.38x | 0.54x | 0.39x | 0.34x | 0.00x |
| Equity ratio | 77.9% | 53.8% | 58.2% | 54.5% | 54.2% | 56.2% | — |
| Interest coverage | 10.03x | 33.11x | 9.26x | 7.16x | 9.51x | 23.72x | — |
| R&D as a share of sales | 5.9% | 5.0% | 4.3% | 4.4% | 4.6% | 5.0% | — |
| Buybacks as a share of market value | 9.3% | -16.5% | 1.8% | 0.7% | 3.0% | -0.7% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -7.8% | -4.9% | 4.4% |
| Operating income | -19.0% | -13.1% | -4.7% |
| Net income | -2.8% | -4.8% | 0.5% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 31.1% | 29.5% | 28.7% | 31.2% |
| Operating margin | 9.8% | 10.4% | 10.3% | 12.1% |
| Net margin | 10.8% | 10.1% | 9.8% | 11.0% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 28.4 | 14.9 | 17.4 | 21.1 | 24.6 | 28.1 | 18.8 | 20.6 | 50.0 |
| Price to sales | 2.7 | 1.8 | 1.9 | 1.7 | 2.2 | 2.7 | 2.4 | 2.2 | 5.6 |
Dividends and splits
Per share, in the currency the company pays
Paid for 9 years. Last went ex-dividend on 10 Jun 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 0.50 | 0.35 | 1.069 | 0.385 | 0.539 | 0.385 | 1.154 | 0.231 |
- 13-for-10 split · 5 Jun 2024
- 2-for-1 split · 25 Sept 2017
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.